412
Views
54
CrossRef citations to date
0
Altmetric
Commentary

Acute exacerbation of COPD: is it the “stroke of the lungs”?

, &
Pages 1579-1586 | Published online: 13 Jul 2016

References

  • RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Resp Crit Care Med2007176653255517507545
  • WHOChronic Obstructive Pulmonary Disease (COPD)GenevaWorld Health Organization2011 Available from: www.who.int/respiratory/copdAccessed January 3, 2016
  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease revised2014 Available from: http://www.who.int/respiratory/copd/management/en/Accessed January 3, 2016
  • OrnekTTorMAltınRClinical factors affecting the direct cost of patients hospitalized with acute exacerbation of chronic obstructive pulmonary diseaseInt J Med Sci20129428529022701335
  • PatelJGNagarSPDalalAAIndirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United StatesInt J Chron Obstruct Pulmon Dis2014928930024672234
  • National Heart, Lung, and Blood InstituteMorbidity and Mortality 2009: Chart Book on Cardiovascular, Lung and Blood DiseasesBethesdaNational Institutes of Health2009
  • FletcherMJUptonJTaylor-FishwickJCOPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age populationBMC Public Health20111161221806798
  • HalpinDMMiravitllesMChronic obstructive pulmonary disease: the disease and its burden to societyProc Am Thorac Soc20063761962316963544
  • DarnellKDwivediAKWengZPanosRJDisproportionate utilization of healthcare resources among veterans with COPD: a retrospective analysis of factors associated with COPD healthcare costCost Eff Resour Alloc2013111323763761
  • HillemanDDewanNMaleskerMFriedmanMPharmacoeconomic evaluation of COPDChest200011851278128511083675
  • TeoWTanWSChongWEconomic burden of chronic obstructive pulmonary diseaseRespirology201217112012621954985
  • FletcherECPetoRThe natural history of chronic airflow obstructionBr Med J1977116451648871704
  • KannerRERenzettiADJrKlauberMRSmithCBGoldenCAVariables associated with changes in spirometry in patients with obstructive lung diseasesAm J Med1979674450313706
  • KannerREAnthonisenNRConnettJELower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild obstructive pulmonary disease: Results from the lung health studyAm J Respir Crit Care Med200116435836411500333
  • DonaldsonGCSeemungalTARBhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax20025784784512324669
  • HalpinDMDecramerMCelliBKestenSLiuDTashkinDPExacerbation frequency and course of COPDInt J Chron Obstruct Pulmon Dis2012765366123055714
  • MakrisDMoschandreasJDamianakiAExacerbations and lung function decline in COPD: new insights in current and ex-smokersRespir Med20071011305131217112715
  • BhowmikASeemungalTASapsfordRJWedzichaJARelation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbationsThorax20005511412010639527
  • GroenewegenKHDentenerMAWoutersEFLongitudinal follow-up of systemic inflammation after acute exacerbations of COPDRespir Med20071012409241517644367
  • SeemungalTADonaldsonGCBhowmikAJeffriesDJWedzichaJATime course and recovery of exacerbations in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20001611608161310806163
  • WedzichaJADonaldsonGCExacerbations of chronic obstructive pulmonary diseaseRespir Care2003481204121314651761
  • BourbeauJFordGZackonHPinskyNLeeJRubertoGImpact on patients’ health status following early identification of a COPD exacerbationEur Respir J20073090791317715163
  • ConnorsAFDawsonNVThomasCOutcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)Am J Respir Crit Care1996154959967
  • SpencerSJonesPWTime course of recovery of health status following an infective exacerbation of chronic bronchitisThorax200358847852
  • SpencerSCalverleyPMBurgePSJonesPWImpact of preventing exacerbations on deterioration of health status in COPDEur Respir J20042369870215176682
  • DonaldsonGCWedzichaJAThe causes and consequences of seasonal variation in COPD exacerbationsInt J Chron Obstruct Pulmon Dis201491101111025336941
  • HurstJDonaldsonGCQuintJGoldringJBaghai-RavaryRWedzichaJTemporal clustering of exacerbations in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200917936937419074596
  • CrinionSCotterOKennedyBCOPD exacerbations – a comparison of Irish data with European data from the ERS COPD auditIr Med J2013106270272
  • GroenewegenKHScholsAMWoutersEFMortality and mortality-related factors after hospitalization for acute exacerbation of COPDChest200312445946712907529
  • AdabagASTherneauTMGershBJWestonSARogerVLSudden death after myocardial infarctionJAMA20083002022202918984889
  • ChaudhrySIKhanRFChenJNational trends in recurrent AMI hospitalizations 1 year after acute myocardial infarction in Medicare beneficiaries: 1999–2010J Am Heart Assoc201435e00119725249298
  • HawkesALPatraoTAWareRAthertonJJTaylorCBOldenburgBFPredictors of physical and mental health-related quality of life outcomes among myocardial infarction patientsBMC Cardiovasc Disord2013136924020831
  • ZamanSKovoorPSudden cardiac death early after myocardial infarction: pathogenesis, risk stratification, and primary preventionCirculation2014129232426243524914016
  • DonaldsonGCWilkinsonTMHurstJRPereraWRWedzichaJAExacerbations and time spent outdoors in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200517144645215579723
  • DewanNARafiqueSKanwarBAcute exacerbations of COPD. Factors associated with poor treatment outcomesChest200011766267110712989
  • Garcia-AymerichJMonsóEMarradesRMRisk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM studyAm J Respir Crit Care Med20011641002100711587986
  • SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1998157141814229603117
  • Soler-CataluñaJJMartínez-GarcíaMARomán SánchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
  • Domingo-SalvanyALamarcaRFerrerMHealth-related quality of life and mortality in male patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200216668068512204865
  • DollRPetoRWheatleyKGrayRSutherlandIMortality in relation to smoking: 40 years’ observations on male British doctorsBMJ19943099019117755693
  • TakahashiTKobayashiSFujinoNIncreased circulating endothelial microparticles in COPD exacerbation susceptibilityThorax2012671067107422843558
  • TakahashiTKobayashiSFujinoNAnnual FEV1 changes and numbers of circulating endothelial microparticles in patients with COPD: a prospective studyBMJ Open20144e004571
  • McAllisterDAMaclayJDMillsNLArterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20071761208121417885263
  • LöfdahlCGCOPD and co-morbidities, with special emphasis on cardiovascular conditionsClin Respir J20082Suppl 1596320298351
  • SinDDWuLManSFThe relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literatureChest20051271952195915947307
  • EngströmGWollmerPHedbladBJuul-MöllerSValindSJanzonLOccurrence and prognostic significance of ventricular arrhythmia is related to pulmonary function: a study from ‘men born in 1914,’ Malmö, SwedenCirculation20011033086309111425773
  • ManninoDMWattGHoleDThe natural history of chronic obstructive pulmonary diseaseEur Respir J20062762764316507865
  • QuintJKHerrettEBhaskaranKEffect of beta blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare recordsBMJ2013347f665024270505
  • DonaldsonGCHurstJRSmithCJHubbardRBWedzichaJAIncreased risk of myocardial infarction and stroke following exacerbation of COPDChest20101371091109720022970
  • SelvarajCLGurmHSGuptaREllisSGBhattDLChronic obstructive pulmonary disease as a predictor of mortality in patients undergoing percutaneous coronary interventionAm J Cardiol20059675675916169353
  • LeavittBJRossCSSpenceBLong-term survival of patients with chronic obstructive pulmonary disease undergoing coronary artery bypass surgeryCirculation20061141 SupplI430I43416820614
  • AndellPKoulSMartinssonAImpact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarctionOpen Heart201411e00000225332773
  • HisebøGRBakkePSAanerudMPredictors of exacerbations in chronic obstructive pulmonary disease – Results from the Bergen COPD cohort studyPLoS One2014910e10972125279458
  • CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med200735677578917314337
  • TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
  • HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med20103631128113820843247
  • DonaldsonGCSeemungalTAPatelISLloyd-OwenSJWilkinsonTMWedzichaJALongitudinal changes in the nature, severity and frequency of COPD exacerbationsEur Respir J20032293193614680081
  • PatelISSeemungalTARWiksMLloyd-OwenSJDonaldsonGCWedzichaJARelationship between bacterial colonization and the frequency, character and severity of COPD exacerbationsThorax20025775976412200518
  • EstebanCArosteguiIAbustoMInfluence of changes in physical activity on frequency of hospitalization in chronic obstructive pulmonary diseaseRespirology20141933033824483954
  • SeemungalTHarper-OwenRBhowmikARespiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic pulmonary diseaseAm J Respir Crit Care Med20011641618162311719299
  • ChangCYaoWTime course of inflammation resolution in patients with frequent exacerbations of chronic obstructive pulmonary diseaseMed Sci Monit20142031132024569299
  • DonaldsonGSSeemungalTAPatelISAirway and systemic inflammation and decline of lung function in patients with COPDChest20051281995200516236847
  • DunlaySMWestonSAKillianJMBellMRJaffeASRogerVLThirty-day rehospitalizations after acute myocardial infarction: a cohort studyAnn Intern Med20121571111822751756
  • BangCNGislasonGHGreveAMNew-onset atrial fibrillation is associated with cardiovascular events leading to death in a first time myocardial infarction population of 89,703 patients with long-term follow-up: a nationwide studyJ Am Heart Assoc201431e00038224449803
  • HalpinDMDecramerMCelliBKestenSLeimerITashkinDPRisk of nonlower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT® trialLung201118926126821678045
  • KesslerRStahlEVogelmeierCPatient understanding, detection, and experience of COPD exacerbations: an observational, interview-based studyChest200613013314216840393
  • RuoBRumsfeldJSHlatkyMALiuHBrownerWSWhooleyMADepressive symptoms and health-related quality of life: The heart and soul studyJAMA2003290221522112851276
  • GunenHHacievliyagilSSKosarFFactors affecting survival of hospitalised patients with COPDEur Respir J200526223424116055870
  • GroenewegenKHScholsAMWoutersEFMortality and mortality-related factors after hospitalization for acute exacerbation of COPDChest2003124245946712907529
  • JokhadarMJacobsenSJReederGSWestonSARogerVLSudden death and recurrent ischemic events after myocardial infarction in the communityAm J Epidemiol20041591040104615155288
  • BrochardLManceboJWysockiMNoninvasive ventilation for acute exacerbations of chronic obstructive pulmonary diseaseN Engl J Med1995333138178227651472
  • BottJCarrollMPConwayJHRandomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways diseaseLancet19933418860155515578099639
  • DivoMCoteCde TorresJPComorbidities and risk of mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012186215516122561964
  • SinDDManSFChronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortalityProc Am Thorac Soc20052181116113462
  • BrekkePHOmlandTSmithPSøysethVUnderdiagnosis of myocardial infarction in COPD – Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbationRespir Med200810291243124718595681
  • HuangBYangYZhuJClinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: Results from a multicenter atrial fibrillation registry studyJ Am Med Dir Assoc201415857658124894999
  • KonecnyTParkJYSomersKRRelation of chronic obstructive pulmonary disease to atrial and ventricular arrhythmiasAm J Cardiol2014114227227724878126
  • TsiligianniIGKosmasEVan der MolenTTzanakisNManaging comorbidity in COPD: A difficult taskCurr Drug Targets201314215817623256716
  • FumagalliGFabianiFForteSINDACO project: a pilot study on incidence of comorbidities in COPD patients referred to pneumology unitsMultidiscip Respir Med2013812823551874